B Eliasson, J Cederholm, P Nilsson, S … - Diabetic Medicine, 2005 - ingentaconnect.com Guidelines for the treatment of risk factors in diabetes care have been updated
recently, due to indisputable results from clinical end-point trials. This study
evaluates risk factor control compared with current national and ... Cited by 54 - Related articles - BL Direct - All 3 versions
S de Lusignan, C Sismanidis, IM Carey, S … - BMC Family Practice, 2005 - biomedcentral.com Type 2 diabetes is an important cause of morbidity and mortality. Its prevalence
appears to be increasing. Guidelines exist regarding its management.
Recommendations regarding drug therapy have changed. Little is known about ... Cited by 47 - Related articles - Cached - All 6 versions
M Fahlen, B Eliasson, A Oden - Diabetic medicine, 2005 - journalia.se The long-acting basal insulin analogue glargine, combined with multiple daily
insulin injections (MDI), has been found to be more effective than the
intermediate-acting NPH with MDI [1]. Furthermore, continuous subcutaneous ... Cited by 21 - Related articles - View as HTML - All 6 versions
- ►easd.org [PDF] JM Jonasson, R Ljung, M Talbäck, B Haglund, S … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis In the light of a report suggesting that insulin
glargine may increase cancer occurrence, the EASD asked us to perform this
study. Methods We followed 114,841 individuals who had a prescription ... Cited by 25 - Related articles - All 7 versions
MR LE, SG RNSDOTTIR, B Eliasson, PM … - Journal of internal medicine, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 18 - Related articles - BL Direct - All 4 versions
JJ Puder, U Keller - Blood pressure - smw.ch Treatment of type 2 diabetes mellitus has ex- panded from treating blood glucose
in the diag- nosed diabetic patient with a view to reducing di- abetic
complications to the prevention of new cases and early detection of the ... Cited by 16 - Related articles - View as HTML - BL Direct - All 4 versions
- Free from Publisher J Fagerudd, C Forsblom, K Pettersson- … - Diabetes care, 2004 - Am Diabetes Assoc The Finnish Diabetic Nephropathy (FinnDiane) study is a nation-wide,
prospective, multicenter study initiated in November 1997 with the primary aim
to identify genetic and environmental risk factors for diabetic nephropathy ... Cited by 14 - Related articles - BL Direct - All 6 versions
B Eliasson, K Eeg-Olofsson, J Cederholm, PM … - Diabetes and Metabolism, 2007 - Elsevier Insulin was frequently used in DM2 patients with long duration of diabetes,
although the mean HbA 1c increased and only a few in this group reached HbA 1c <
7.0%. Patients showing long-term improvement in HbA 1c (> 1%) from 1996 to ... Cited by 6 - Related articles - BL Direct - All 2 versions
AL Fairchild, A Alkon - Journal of health politics, policy and law, 2007 - Duke Univ Press Abstract The control of infectious diseases has traditionally fallen to public
health and the clinical care of chronic diseases to private medicine. In New
York City, how- ever, the Department of Health and Mental Hygiene (DOHMH) ... Cited by 6 - Related articles - BL Direct - All 4 versions
